| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.03 |